Literature DB >> 11469682

Protective effect of oral phosphatidylcholine on radiation-induced release of intestinal peptidases in rats.

M Fittkau1, R Gerlach, H J Schmoll.   

Abstract

PURPOSE: To investigate whether phosphatidylcholine (PPC) has a protective effect on mucosa-irradiated rats.
METHODS: The rats were orally fed with 25, 50, and 100 mg PPC/kg body weight (b.w.), respectively, for 3 weeks before irradiation. After administering the medication and 1 day after irradiation, a 20 cm segment of the proximal jejunum was perfused in situ and peptidase activities, as well as the concentrations of the membrane components, were assayed.
RESULTS: We have shown that the application of a low dose of 25 mg PPC/kg b.w. daily for 21 days can prevent damage to membranes induced by 2.0 Gy as represented in the peptidase release profiles during the perfusion of the proximal jejunum of rats. Higher dose levels did not increase the protective effect.
CONCLUSIONS: These findings suggest that a low dosage of exogenous PPC is capable of hindering the impairment of membranes induced by a small dose of radiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469682     DOI: 10.1007/s004320100244

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  2 in total

1.  Enhanced cellular radiosensitivity induced by cofilin-1 over-expression is associated with reduced DNA repair capacity.

Authors:  Jyh-Der Leu; Yu-Wen Chiu; Chia-Chien Lo; Pei-Hsun Chiang; Shu-Jun Chiu; Cheng-Han Tsai; Jeng-Jong Hwang; Ran-Chou Chen; Vera Gorbunova; Yi-Jang Lee
Journal:  Int J Radiat Biol       Date:  2013-03-19       Impact factor: 2.694

2.  Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats.

Authors:  Marina Fittkau; Wieland Voigt; Hans-Jürgen Holzhausen; Hans-Joachim Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.